Melissa Perchellet, MD

Department of Psychiatry, Division Of Addiction Psychiatry, University of Kansas Medical Center, Kansas City, Kansas

PCC
Buprenorphine for Pain in Sickle Cell Disease
Review Article

June 16, 2026

Buprenorphine is associated with improved functional outcomes as well as reduced ED visits, hospital admissions, and opioid use in patients with chronic pain related to sickle cell disease.
, , , et al

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe